Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
China flag China · Delayed Price · Currency is CNY
35.38
+0.03 (0.08%)
Feb 4, 2026, 3:04 PM CST

SHE:002864 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
1,096971.45978.2971.04883.76667.66
Other Revenue
2.412.412.633.263.732.66
1,098973.86980.83974.29887.48670.31
Revenue Growth (YoY)
11.91%-0.71%0.67%9.78%32.40%9.77%
Cost of Revenue
505.81381.74413.74408.25370.36255.52
Gross Profit
592.58592.12567.09566.04517.12414.79
Selling, General & Admin
420.6436.86418.79416.11386.15305.6
Research & Development
37.7937.5420.2618.2314.0312.97
Other Operating Expenses
16.459.3510.6110.239.297.15
Operating Expenses
480.17485.59453.98452.94414.07329.39
Operating Income
112.41106.53113.11113.1103.0585.39
Interest Expense
-1.31-1.56-6.11-13.92-3.49-2.85
Interest & Investment Income
20.0925.5822.0617.1811.788.32
Other Non Operating Income (Expenses)
-4.99-0.220.312.55-5.271.19
EBT Excluding Unusual Items
126.2130.32129.37118.91106.0692.06
Gain (Loss) on Sale of Investments
-0--1.56-0.11--
Gain (Loss) on Sale of Assets
0.12-0.010.17--0.15
Asset Writedown
-0.38-0.18-0.81-0.08-0-0.19
Other Unusual Items
16.156.822.080.462.972.49
Pretax Income
142.08136.95129.25119.18109.0394.5
Income Tax Expense
21.8417.0317.716.0314.4713.4
Earnings From Continuing Operations
120.24119.92111.55103.1594.5681.09
Minority Interest in Earnings
0.260.35-1.11-1.98-1.39-1.98
Net Income
120.51120.27110.43101.1693.1779.12
Net Income to Common
120.51120.27110.43101.1693.1779.12
Net Income Growth
3.97%8.91%9.16%8.58%17.77%10.22%
Shares Outstanding (Basic)
10510596868586
Shares Outstanding (Diluted)
10510598868586
Shares Change (YoY)
-2.47%7.02%13.03%1.16%-0.60%-0.56%
EPS (Basic)
1.151.151.151.181.090.92
EPS (Diluted)
1.151.151.131.171.090.92
EPS Growth
6.61%1.77%-3.42%7.34%18.48%10.84%
Free Cash Flow
45.1374.5441.5369.5335.3621.06
Free Cash Flow Per Share
0.430.710.420.800.410.24
Dividend Per Share
0.3500.2500.2200.2000.1800.150
Dividend Growth
59.09%13.64%10.00%11.11%20.00%-
Gross Margin
53.95%60.80%57.82%58.10%58.27%61.88%
Operating Margin
10.23%10.94%11.53%11.61%11.61%12.74%
Profit Margin
10.97%12.35%11.26%10.38%10.50%11.80%
Free Cash Flow Margin
4.11%7.65%4.23%7.14%3.98%3.14%
EBITDA
146.91139.02142.92130.16117.899.85
EBITDA Margin
13.38%14.27%14.57%13.36%13.27%14.89%
D&A For EBITDA
34.532.4929.8117.0714.7414.45
EBIT
112.41106.53113.11113.1103.0585.39
EBIT Margin
10.23%10.94%11.53%11.61%11.61%12.74%
Effective Tax Rate
15.37%12.43%13.70%13.45%13.27%14.19%
Revenue as Reported
1,098973.86980.83974.29887.48670.31
Advertising Expenses
-5.041.091.763.680.62
Source: S&P Global Market Intelligence. Standard template. Financial Sources.